Miridesap
Miridesap is an antineoplastic which depletes circulating serum amyloid P component (SAP) almost completely but leaves some SAP in amyloid deposits for specific recognition by subsequently administered therapeutic anti-SAP antibodies.
| Trivial name | Ro-638695; GSK 2315698; CPHPC |
| Catalog Number | CSN20505 |
| Alternative Name(s) | Ro-638695; GSK 2315698; CPHPC |
| Research Area | Neurological Disease |
| Molecular Formula | C16H24N2O6 |
| CAS# | 224624-80-0 |
| Purity | ≥97% |
| SMILES | O=C(N1[C@@H](C(O)=O)CCC1)CCCCC(N2[C@@H](C(O)=O)CCC2)=O |
| Size | 5mg |
| Supplier Page | https://www.csnpharm.com/products/miridesap.html |